| 1 |
Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group
Claudio Vitali, S Bombardieri, R Jonsson et al. · Annals of the Rheumatic Diseases
Open access |
Jun 2002 |
5,366 |
| 2 |
Multicenter, Placebo-Controlled Trial of Lorcaserin for Weight Management
Steven R. Smith, Neil J. Weissman, Christen M. Anderson et al. · New England Journal of Medicine
Open access |
14 Jul 2010 |
912 |
| 3 |
A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity‐related risk factors (COR‐II)
Caroline M. Apovian, Louis J. Aronne, Domenica Rubino et al. · Obesity
Open access |
14 Feb 2013 |
722 |
| 4 |
Regulation of Serotonin1A, Glucocorticoid, and Mineralocorticoid Receptor in Rat and Human Hippocampus: Implications for the Neurobiology of Depression
Juan F. López, Derek T. Chalmers, Karley Y. Little et al. · Biological Psychiatry
|
Apr 1998 |
703 |
| 5 |
(d)-β-Hydroxybutyrate Inhibits Adipocyte Lipolysis via the Nicotinic Acid Receptor PUMA-G
Andrew K.P. Taggart, Jukka Kero, Xiaodong Gan et al. · Journal of Biological Chemistry
Open access |
Jun 2005 |
660 |
| 6 |
Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1
Michael W. Melkus, Jacob D. Estes, Angela Padgett‐Thomas et al. · Nature Medicine
|
22 Oct 2006 |
660 |
| 7 |
GPR41/FFAR3 and GPR43/FFAR2 as Cosensors for Short-Chain Fatty Acids in Enteroendocrine Cells vs FFAR3 in Enteric Neurons and FFAR2 in Enteric Leukocytes
Mark Klitgaard Nøhr, Maria H. Pedersen, Andreas Gille et al. · Endocrinology
|
25 Jul 2013 |
596 |
| 8 |
A One-Year Randomized Trial of Lorcaserin for Weight Loss in Obese and Overweight Adults: The BLOSSOM Trial
Meredith C. Fidler, Matilde Sanchez, Brian Raether et al. · The Journal of Clinical Endocrinology & Metabolism
|
27 Jul 2011 |
561 |
| 9 |
Randomized Placebo‐Controlled Clinical Trial of Lorcaserin for Weight Loss in Type 2 Diabetes Mellitus: The BLOOM‐DM Study
Patrick Mahlen O'Neil, Steven R. Smith, Neil J. Weissman et al. · Obesity
|
16 Mar 2012 |
530 |
| 10 |
Tyro-3 family receptors are essential regulators of mammalian spermatogenesis
Qingxian Lu, Martin Gore, Qing Zhang et al. · Nature
|
Apr 1999 |
516 |
| 11 |
2016 Focused Update: Clinical Recommendations for Cardiopulmonary Exercise Testing Data Assessment in Specific Patient Populations
Marco Guazzi, Ross A Arena, Martin Halle et al. · Circulation
Open access |
2 May 2016 |
456 |
| 12 |
Lorcaserin, a Novel Selective Human 5-Hydroxytryptamine2C Agonist: in Vitro and in Vivo Pharmacological Characterization
William J. Thomsen, Andrew J. Grottick, Frederique Menzaghi et al. · Journal of Pharmacology and Experimental Therapeutics
|
6 Feb 2008 |
405 |
| 13 |
A Role for Intestinal Endocrine Cell-Expressed G Protein-Coupled Receptor 119 in Glycemic Control by Enhancing Glucagon-Like Peptide-1 and Glucose-Dependent Insulinotropic Peptide Release
Zhi‐Liang Chu, Christopher J. Carroll, Jean Alfonso et al. · Endocrinology
|
17 Jan 2008 |
387 |
| 14 |
Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): two randomised, double-blind, placebo-controlled, phase 3 studies
William J. Sandborn, Severine A.R.A. Vermeire, Laurent Peyrin‐Biroulet et al. · The Lancet
Open access |
2 Mar 2023 |
363 |
| 15 |
Marine Protected Areas: Tools for Sustaining Ocean Ecosystems
Peter H. Flournoy · Journal of International Wildlife Law & Policy
|
2003 |
357 |
| 16 |
A heterodimer-selective agonist shows in vivo relevance of G protein-coupled receptor dimers
Maria Waldhoer, Jamie C Fong, Robert M. Jones et al. · Proceedings of the National Academy of Sciences
Open access |
2 Jun 2005 |
344 |
| 17 |
Seven transmembrane G protein-coupled receptor repertoire of gastric ghrelin cells
Maja Storm Engelstoft et al. · Molecular Metabolism
Open access |
3 Sep 2013 |
325 |
| 18 |
Arcuate Glucagon-Like Peptide 1 Receptors Regulate Glucose Homeostasis but Not Food Intake
Darleen A. Sandoval, Didier Bagnol, Stephen C. Woods et al. · Diabetes
Open access |
16 May 2008 |
324 |
| 19 |
Role of GPR81 in lactate-mediated reduction of adipose lipolysis
Tian‐Quan Cai, Ning Ren, Lan Jin et al. · Biochemical and Biophysical Research Communications
|
25 Oct 2008 |
308 |
| 20 |
A Role for β-Cell-Expressed G Protein-Coupled Receptor 119 in Glycemic Control by Enhancing Glucose-Dependent Insulin Release
Zhi‐Liang Chu, Robert M. Jones, Hongmei He et al. · Endocrinology
|
9 Feb 2007 |
295 |
| 21 |
Efficacy and Safety of Etrasimod in a Phase 2 Randomized Trial of Patients With Ulcerative Colitis
William J. Sandborn, Laurent Peyrin‐Biroulet, Jinkun Zhang et al. · Gastroenterology
Open access |
8 Nov 2019 |
236 |
| 22 |
Functional assays for screening GPCR targets
William J. Thomsen, John M. Frazer, David J. Unett · Current Opinion in Biotechnology
Review |
21 Nov 2005 |
224 |
| 23 |
International Union of Basic and Clinical Pharmacology. LXXXII: Nomenclature and Classification of Hydroxy-carboxylic Acid Receptors (GPR81, GPR109A, and GPR109B)
Stefan Offermanns, Steven L. Colletti, Timothy W. Lovenberg et al. · Pharmacological Reviews
Open access |
26 Apr 2011 |
205 |
| 24 |
Discovery and Structure−Activity Relationship of (1R)-8-Chloro-2,3,4,5-tetrahydro-1-methyl-1H-3-benzazepine (Lorcaserin), a Selective Serotonin 5-HT2C Receptor Agonist for the Treatment of Obesity
Brian M. Smith et al. · Journal of Medicinal Chemistry
Open access |
21 Dec 2007 |
202 |
| 25 |
CaMKIIδ Isoforms Differentially Affect Calcium Handling but Similarly Regulate HDAC/MEF2 Transcriptional Responses
Tong Zhang, Michael Kohlhaas, Johannes Backs et al. · Journal of Biological Chemistry
Open access |
9 Oct 2007 |
202 |
| 26 |
Lorcaserin (APD356), a Selective 5‐HT2CAgonist, Reduces Body Weight in Obese Men and Women
Steven R. Smith, Warren A. Prosser, David J. Donahue et al. · Obesity
|
4 Dec 2008 |
191 |
| 27 |
Langerhans Cells Release Prostaglandin D2 in Response to Nicotinic Acid
Dominique Maciejewski-Lenoir, Jeremy G. Richman, Yaron Hakak et al. · Journal of Investigative Dermatology
Open access |
28 Sep 2006 |
190 |
| 28 |
Salting-Out Assisted Liquid–Liquid Extraction for Bioanalysis
Yong Q. Tang, Naidong Weng · Bioanalysis
|
Jun 2013 |
177 |
| 29 |
GPR119 agonists for the treatment of type 2 diabetes
Robert M Jones, James N. Leonard, Daniel J. Buzard et al. · Expert Opinion on Therapeutic Patents
|
28 Sep 2009 |
156 |
| 30 |
Modulation of sphingosine-1-phosphate in inflammatory bowel disease
Laurent Peyrin‐Biroulet, Ronald J. Christopher, Dominic P. Behan et al. · Autoimmunity Reviews
|
7 Mar 2017 |
155 |
| 31 |
Discovery of the First Potent and Orally Efficacious Agonist of the Orphan G-Protein Coupled Receptor 119
Graeme Semple, Beatriz Fioravanti, Guilherme Rocha Pereira et al. · Journal of Medicinal Chemistry
Open access |
13 Aug 2008 |
143 |
| 32 |
Serologic Response to Messenger RNA Coronavirus Disease 2019 Vaccines in Inflammatory Bowel Disease Patients Receiving Biologic Therapies
Serre-Yu Wong et al. · Gastroenterology
Open access |
20 Apr 2021 |
141 |
| 33 |
Therapeutic Utility of Cannabinoid Receptor Type 2 (CB2) Selective Agonists
Sangdon Han, Jayant Thatte, Daniel J. Buzard et al. · Journal of Medicinal Chemistry
Open access |
18 Jul 2013 |
134 |
| 34 |
Lorcaserin, A 5-HT2CReceptor Agonist, Reduces Body Weight by Decreasing Energy Intake without Influencing Energy Expenditure
Corby K. Martin, Leanne Maree Redman, Jinkun Zhang et al. · The Journal of Clinical Endocrinology & Metabolism
Open access |
29 Dec 2010 |
134 |
| 35 |
Mindfulness-based training attenuates insula response to an aversive interoceptive challenge
Lori Haase, Nate J. Thom, Akanksha Shukla et al. · Social Cognitive and Affective Neuroscience
Open access |
8 Apr 2014 |
128 |
| 36 |
N-Oleoyldopamine Enhances Glucose Homeostasis through the Activation of GPR119
Zhi‐Liang Chu, Christopher J. Carroll, Ruoping Chen et al. · Molecular Endocrinology
Open access |
10 Nov 2009 |
127 |
| 37 |
Niacin Lipid Efficacy Is Independent of Both the Niacin Receptor GPR109A and Free Fatty Acid Suppression
Brett P. Lauring et al. · Science Translational Medicine
|
22 Aug 2012 |
127 |
| 38 |
The effect of vitamin D on renin–angiotensin system activation and blood pressure
Ciaran J. McMullan, Lea Borgi, Gary C. Curhan et al. · Journal of Hypertension
Open access |
30 Dec 2016 |
126 |
| 39 |
Glucagon-like peptide-1 and the exenatide analogue AC3174 improve cardiac function, cardiac remodeling, and survival in rats with chronic heart failure
Que Liu, Christen M. Anderson, Anatoly Broyde et al. · Cardiovascular Diabetology
Open access |
16 Nov 2010 |
124 |
| 40 |
Pharmacokinetics and Tolerability of Multiple Doses of Pharmaceutical-Grade Synthetic Cannabidiol in Pediatric Patients with Treatment-Resistant Epilepsy
James W. Wheless, Dennis Dlugos, Ian Miller et al. · CNS Drugs
Open access |
2 May 2019 |
114 |
| 41 |
Long-term Safety and Efficacy of Etrasimod for Ulcerative Colitis: Results from the Open-label Extension of the OASIS Study
Severine A.R.A. Vermeire, Michael V. Chiorean, Julián Panés et al. · Journal of Crohn s and Colitis
Open access |
19 Jan 2021 |
109 |
| 42 |
The use of constitutively active GPCRs in drug discovery and functional genomics
Derek T. Chalmers, Dominic P. Behan · Nature Reviews Drug Discovery
Review |
Aug 2002 |
109 |
| 43 |
A double dissociation between serial reaction time and radial maze performance in rats subjected to 192 IgG‐saporin lesions of the nucleus basalis and/or the septal region
Olivia Lehmann, Andrew J. Grottick, J. ‐C. Cassel et al. · European Journal of Neuroscience
Open access |
Aug 2003 |
103 |
| 44 |
Reinstatement of ethanol-seeking behavior by drug cues following single versus multiple ethanol intoxication in the rat: effects of naltrexone
Roberto Ciccocioppo, Daniel C.-H. Lin, Rémi Martin‐Fardon et al. · Psychopharmacology
|
27 Mar 2003 |
102 |
| 45 |
GCR1 , the putative Arabidopsis G protein-coupled receptor gene is cell cycle-regulated, and its overexpression abolishes seed dormancy and shortens time to flowering
Gabriella Colucci, Fabio Apone, Nicole Alyeshmerni et al. · Proceedings of the National Academy of Sciences
Open access |
2 Apr 2002 |
102 |
| 46 |
Regulation of 5‐HT Receptors and the Hypothalamic‐Pituitary‐Adrenal Axis
Juan F. López, Delia M. Vázquez, Derek T. Chalmers et al. · Annals of the New York Academy of Sciences
Open access |
Dec 1997 |
100 |
| 47 |
3-(1 H -Tetrazol-5-yl)-1,4,5,6-tetrahydro-cyclopentapyrazole (MK-0354): A Partial Agonist of the Nicotinic Acid Receptor, G-Protein Coupled Receptor 109a, with Antilipolytic but No Vasodilatory Activity in Mice
Graeme Semple et al. · Journal of Medicinal Chemistry
Open access |
30 Jul 2008 |
99 |
| 48 |
Nicotinic Acid Receptor Agonists Differentially Activate Downstream Effectors
Jeremy G. Richman, Martha Kanemitsu-Parks, Ibragim Gaidarov et al. · Journal of Biological Chemistry
Open access |
24 Apr 2007 |
99 |
| 49 |
Global analysis of G‐protein‐coupled receptor signaling in human tissues
Yaron Hakak, Devin Shrestha, Moira C. Goegel et al. · FEBS Letters
Open access |
30 Jul 2003 |
95 |
| 50 |
Glabellar Contraction Patterns: A Tool to Optimize Botulinum Toxin Treatment
Ada Regina Trindade de Almeida, Elisa Raquel Martins da Costa Marques, Raul A. Banegas et al. · Dermatologic Surgery
|
17 Jul 2012 |
91 |